Published in Cancer on July 15, 1980
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Adenocarcinoma of the small intestine complicating Crohn's disease. Gut (1982) 1.40
Adenocarcinoma and lymphoma of the small intestine. Distribution and etiologic associations. Ann Surg (1983) 1.36
Carcinoma in anal Crohn's disease: discussion paper. J R Soc Med (1988) 1.15
Severe gastrointestinal hemorrhage in Crohn's disease. Ann Surg (1991) 1.11
Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg (1989) 1.10
Anal carcinoma in patients with Crohn's disease. Ann Surg (1984) 1.00
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis (2011) 0.95
Malignant transformation of anal skin tags in Crohn's disease. Gut (1984) 0.90
Intestinal cancer in patients with Crohn's disease. Int J Colorectal Dis (2006) 0.88
Stomal adenocarcinoma in Crohn's disease. Gut (1990) 0.86
Small bowel adenocarcinoma and Crohn's disease: any further ahead than 50 years ago? World J Gastroenterol (2014) 0.82
Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol (2014) 0.81
The malignant potential of colorectal Crohn's disease. Ann R Coll Surg Engl (1987) 0.81
Colorectal adenocarcinoma in Crohn's disease. Ann Surg (1996) 0.78
Establishment and characterization of HROC69 - a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft. Sci Rep (2016) 0.75
Intestinal cancer in Crohn's disease. Bull N Y Acad Med (1984) 0.75
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med (1978) 15.13
General practitioner's perceptions of the route to evidence based medicine: a questionnaire survey. BMJ (1998) 13.39
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
Randomized versus historical controls for clinical trials. Am J Med (1982) 7.53
Performance indicators for primary care groups: an evidence based approach. BMJ (1998) 6.97
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
A method for assessing the quality of a randomized control trial. Control Clin Trials (1981) 6.63
Microbial surfaces in relation to pathogenicity. Bacteriol Rev (1977) 5.79
Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med (2000) 5.68
Intussusception in adults: institutional review. J Am Coll Surg (1999) 5.05
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Bias in treatment assignment in controlled clinical trials. N Engl J Med (1983) 4.78
Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ (2010) 4.53
Publication bias and clinical trials. Control Clin Trials (1987) 4.34
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
MR imaging and T2 mapping of femoral cartilage: in vivo determination of the magic angle effect. AJR Am J Roentgenol (2001) 3.69
Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA (1995) 3.48
Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol (2006) 3.34
Future provision of out of hours primary medical care: a survey with two general practitioner research networks. BMJ (1996) 3.34
Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med (1977) 3.33
Paediatric intensive care transfers. Anaesthesia (2000) 3.32
Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med (1983) 3.04
Appropriateness of use of emergency ambulances. J Accid Emerg Med (1998) 3.02
Rate of regeneration of peripheral nerves in man. J Physiol (1943) 3.02
Transgene-mediated auxin overproduction in Arabidopsis: hypocotyl elongation phenotype and interactions with the hy6-1 hypocotyl elongation and axr1 auxin-resistant mutants. Plant Mol Biol (1995) 3.01
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Infection and diabetes: the case for glucose control. Am J Med (1982) 2.90
Is perinatal mortality still a good indicator of perinatal care? Paediatr Perinat Epidemiol (1988) 2.87
Pathogenicity of influenza virus. Microbiol Rev (1980) 2.80
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature (1992) 2.61
In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med (1990) 2.61
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med (1981) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Derivatives of 6-aminopenicillanic acid. XI. Alpha-amino-p-hydroxybenzylpenicillin. J Chem Soc Perkin 1 (1971) 2.39
Genetic engineering of harvest index in tobacco through overexpression of a phytochrome gene. Nat Biotechnol (1996) 2.36
Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess (2009) 2.36
Overnight calls in primary care: randomised controlled trial of management using nurse telephone consultation. BMJ (1999) 2.32
Phytochrome and photomorphogenesis in plants. Nature (1970) 2.26
Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet (1984) 2.19
Earthquake injuries related to housing in a guatemalan village. Science (1977) 2.18
Clinical governance in primary care groups: the feasibility of deriving evidence-based performance indicators. Qual Health Care (2000) 2.16
Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). Fam Pract (1997) 2.15
Biochemical challenge of microbial pathogenicity. Bacteriol Rev (1968) 2.14
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene (2007) 2.14
The superior mesenteric artery syndrome. The disease that isn't, or is it? J Clin Gastroenterol (1985) 2.13
The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05
Women's views about management and cause of urinary tract infection: qualitative interview study. BMJ (2010) 2.03
Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial. BMJ (2000) 1.99
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet (1988) 1.98
Groin hernia repair in Scotland. Br J Surg (2000) 1.93
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
Selection from gonococci grown in vitro of a colony type with some virulence properties of organisms adapted in vivo. J Gen Microbiol (1977) 1.85
Anthrax toxic complex. Fed Proc (1967) 1.84
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum. Microb Pathog (1988) 1.81
Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Microb Pathog (1989) 1.80
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med (1992) 1.80
Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut (1979) 1.78
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. J Cell Biol (1997) 1.72
Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. J Gen Microbiol (1988) 1.72
1% or less: a community-based nutrition campaign. Public Health Rep (1998) 1.69
Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet (1991) 1.67
Hydrogenated oils and fats: the presence of chemically-modified fatty acids in human adipose tissue. Am J Clin Nutr (1981) 1.65
Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63
Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res (1998) 1.63
Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59
Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate. Arch Ophthalmol (1980) 1.59
Genome differences among varicella-zoster virus isolates. J Gen Virol (1983) 1.59
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Factors affecting the induction of phenotypically determined serum resistance of Neisseria gonorrhoeae grown in media containing serum or its diffusible components. J Gen Microbiol (1981) 1.58
Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med (1989) 1.57
Penicillin neurotoxicity. Ann N Y Acad Sci (1967) 1.57
A prospective, randomized trial of short versus long tubes in adhesive small-bowel obstruction. Am J Surg (1995) 1.56
Subtyping of hepatitis-associated antigen (HB-Ag); simplified technique with counterelectrophoresis. J Immunol (1972) 1.54
Sensitivity and specificity of clinical trials. Randomized v historical controls. Arch Intern Med (1983) 1.54
Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg (1994) 1.54
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53